Drugmakers complain readability missing from administration on decreasing drug costs

Pharmaceutical executives say that the Trump administration has not offered sufficient particulars as to the way it will obtain the lowered drug costs promised in an Govt Order issued in Might.

That order implents a program generally known as “Most Favored Nation”